Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

NCT03637400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

269

Enrollment

OTHER

Sponsor class

Conditions

Methicillin-resistant Staphylococcus Aureus
Skin Infection

Interventions

DRUG: TMP-SMX
DRUG: DOXY

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborators

[object Object]
[object Object]
[object Object]